BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2015
View Archived Issues
Synaptic activity studied in HSA21-encoded miRNAs
Read More
Data correlates CACNA1B mutation with myoclonus dystonia syndrome
Read More
PRMT5 revealed as a potential biomarker of CLL progression and transformation
Read More
Nestle invests in microbiome therapeutics firm Seres Health
Read More
Tivorsan develops pilot manufacturing process for TVN-102, triggering milestone payments
Read More
Phase I trial results shows potential for GR-MD-02 in NASH patients with fibrosis
Read More
Ultragenyx begins new program for KRN-23 in tumor-induced osteomalacia
Read More
Arena Pharmaceuticals reports data from phase Ib trial of APD-334
Read More
ExterNautics reports discovery of anti-FAT1 MAbs
Read More
Sanofi discloses new TAFIa inhibitors
Read More
Gilead Sciences presents novel PI3Kdelta inhibitors
Read More
Kala Pharmaceuticals patents new VEGFR-2 inhibitors
Read More
China investigators divulge NEP inhibitor prodrugs
Read More
MerLion Pharmaceuticals reports phase II data for finafloxacin in urinary tract infections
Read More
Promising results presented for novel complement inhibitors
Read More
FDA grants orphan drug status to ATR-101 for Cushing's syndrome
Read More
FDA grants fast track designation to Debio-1450 for ABSSSI
Read More
Transgenic Ebola vaccine set to enter phase I trials in China
Read More
Boehringer Ingelheim and BioMed X to discover new epigenetic regulators of COPD
Read More
Intellia Therapeutics and Novartis collaborate on CRISPR/Cas9-based therapies
Read More
Stemline Therapeutics licenses novel reversible inhibitor of XPO1 from CanBas
Read More
Melinta's delafloxacin meets primary endpoint in phase III ABSSSI study
Read More
FDA approves Rytary extended-release capsules for Parkinson's disease
Read More
Conatus announces pharmacokinetic data in support of emricasan development
Read More
FDA approves Savaysa for prevention of embolism and stroke in non-valvular atrial fibrillation
Read More
FDA advisory committee recommends approval of Sandoz biosimilar filgrastim
Read More
Advanced Accelerator Applications acquires Atreus and starts phase I/II trial of imaging agent
Read More
